SIFI SpA - Strategic SWOT Analysis Review

December 2021 | 28 pages | ID: S2F1D400096EN
GlobalData

Abstracts

SIFI SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

SIFI SpA (SIFI) is an integrated ophthalmic company that focuses on eye care products. It develops, manufactures and markets pharmaceutical products, diagnostic instruments and surgical equipment for the prevention and treatment of ocular pathologies. SIFI develops its products in various dosage forms including ointments, eye drops, pills and capsules. Its products find application in the areas of corneal abrasions, cataract, glaucoma, infections, inflammation, dry eye, and retinopathies. It conducts research in the areas of diagnostics and surgery. SIFI operates directly in Italy, Spain, France, Romania, Mexico, and Turkey. SIFI is headquartered in Catania, Italy.

SIFI SpA Key Recent Developments

Jun 09,2021: SIFI to present at BIO Digital International Convention 2021
May 17,2021: SIFI and Bausch Health Russia announce strategic commercial partnership that will ensure greater access to important eye care medicines in Russia
Mar 22,2021: SIFI announces granting of marketing authorizations in Turkey
Dec 07,2020: SIFI appoints Jelle Kleijn as global head of acanthamoeba keratitis to globally lead the effort to deliver the first registered treatment for this rare sight-threatening parasitic eye infection
Mar 23,2020: Covid-19 emergency, SIFI provides Italian hospital units of ophthalmology with products to treat ocular discomfort and prevent potential risks of infection

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

SIFI SpA - Key Facts
SIFI SpA - Key Employees
SIFI SpA - Key Operational Employees
SIFI SpA - Major Products and Services
SIFI SpA - History
SIFI SpA - Company Statement
SIFI SpA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
SIFI SpA - Business Description
R&D Overview
SIFI SpA - SWOT Analysis
SWOT Analysis - Overview
SIFI SpA - Strengths
SIFI SpA - Weaknesses
SIFI SpA - Opportunities
SIFI SpA - Threats
SIFI SpA - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

SIFI SpA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
SIFI SpA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
SIFI SpA, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Jun 09, 2021: SIFI to present at BIO Digital International Convention 2021
May 17, 2021: SIFI and Bausch Health Russia announce strategic commercial partnership that will ensure greater access to important eye care medicines in Russia
Mar 22, 2021: SIFI announces granting of marketing authorizations in Turkey
Dec 07, 2020: SIFI appoints Jelle Kleijn as global head of acanthamoeba keratitis to globally lead the effort to deliver the first registered treatment for this rare sight-threatening parasitic eye infection
Mar 23, 2020: Covid-19 emergency, SIFI provides Italian hospital units of ophthalmology with products to treat ocular discomfort and prevent potential risks of infection

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

SIFI SpA, Key Facts
SIFI SpA, Key Employees
SIFI SpA, Key Operational Employees
SIFI SpA, Major Products and Services
SIFI SpA, History
SIFI SpA, Subsidiaries
SIFI SpA, Key Competitors
SIFI SpA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
SIFI SpA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
SIFI SpA, Recent Deals Summary

List Of Figures

LIST OF FIGURES

SIFI SpA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
SIFI SpA, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021